Responses
Scientific Abstracts
Poster Presentations
Posters
Rheumatoid arthritis – other biologic treatment
FRI0181 Sirukumab, a human anti-IL-6 monoclonal antibody, improves physical function in patients with active ra despite methotrexate therapy: Results from a 2-part, proof-of-concept, dose-ranging, randomized, double-blind, placebo-controlled, phase 2 study
Compose a Response to This Article
Other responses
No responses have been published for this article.